BAUMER (BALM3) Main Indicators
Company Basic DataCompany | BAUMER |
Corporate Name | BAUMER S.A. |
Registration Status | ATIVO |
Issuer Status | FASE OPERACIONAL |
Listing Segment | Tradicional - BOVESPA |
Activity | Fabricação aparelhos e instrumentos p/ uso medico hospitalar e ortopedia |
Share | BALM3 |
Quote Date | 03/26/2025 |
Share Type | ON |
Last Closing | R$ 15.00 |
Quotation Factor | 1 Share |
Financial Volume | R$ 1.50 thousand |
Last Statement | DFP - 12/31/2024 |
Sector | Saúde |
Subsector | Equipamentos |
Segment | Equipamentos |
Participation Indexes | - |
Updated 04/02/2025 |
Relative Prices, Market Cap, EV, and Dividend Yield | |
---|
Price/Earnings | 4.65 |
Price/SBV | 0.83 |
Price/Net Sales | 0.76 |
Price/CFO | 4.70 |
Price/FCF | 6.24 |
Price/Total Assets | 0.51 |
Price/EBIT | 4.09 |
Price/Working Capital | 1.07 |
Price/NCAV | 5.23 |
EV/EBIT | 3.67 |
EV/EBITDA | 3.23 |
EV/Net Sales | 0.68 |
EV/CFO | 4.23 |
EV/FCF | 5.61 |
EV/Total Assets | 0.46 |
Company Market Cap | R$ 132.35 M |
Enterprise Value | R$ 132.21 M |
Current Financial Statement Date | 12/31/2024 |
Current Share Price | R$ 15.00 |
Share Price Date | 03/26/2025 |
Dividend Yield | 4.78% |
Summary Income Statement Last 12 Months | |
---|
Net Revenue | R$ 194.39 M |
Gross Result | R$ 119.81 M |
EBIT | R$ 35.99 M |
Depreciation and Amortization | - R$ 4.99 M |
EBITDA | R$ 40.97 M |
Net Profit | R$ 31.61 M |
Net Profit/Share | R$ 3.23 |
Summary Income Statement Last Quarter | |
---|
Net Revenue | R$ 57.88 M |
Gross Result | R$ 35.73 M |
EBIT | R$ 17.42 M |
Depreciation and Amortization | - R$ 1.25 M |
EBITDA | R$ 18.68 M |
Net Profit | R$ 14.75 M |
Profit/Share | R$ 1.50 |
Stock Price and Stock Volume BehaviorLowest Price 52 weeks | R$ 9.36 |
Highest Price 52 weeks | R$ 15.71 |
Variation 2025 | 8.70% |
Variation 1 year | 41.26% |
Variation 2 years(total) | 73.45% |
Variation 2 years(yearly) | 31.45% |
Variation 3 years(total) | 13.77% |
Variation 3 years(yearly) | 4.42% |
Variation 4 years(total) | 3.76% |
Variation 4 years(yearly) | 0.93% |
Variation 5 years(total) | 58.37% |
Variation 5 years(yearly) | 9.12% |
Average Daily Volume (3 months) | R$ 636.40 |
Updated 04/02/2025 |
Returns, Margins, and Other Measures | |
---|
Return on Initial Tangible Capital | 13.48% |
Return on Initial Invested Capital | 15.76% |
Pre-Tax Return on Initial Tangible Capital | 20.42% |
Pre-Tax Return on Initial Invested Capital | 23.88% |
Return on Initial Shareholder´s Equity | 21.91% |
Return on Initial Asset | 12.65% |
Gross Margin | 61.63% |
Net Margin | 16.26% |
EBIT Margin | 18.51% |
EBITDA Margin | 21.08% |
Initial Asset Turnover | 0.78 |
Financial Leverage | 1.61 |
Liabilities/Net Worth | 0.61 |
Net Debt/EBITDA | 0.00 |
Summary Balance Sheet | |
---|
Cash and Cash Equivalents | R$ 16.86 M |
Total Assets | R$ 286.67 M |
Short-Term Debt | R$ 2.72 M |
Long-Term Debt | R$ 14.00 M |
Gross Debt | R$ 16.73 M |
Net Debt | - R$ 137.00 thousand |
Shareholder´s Equity | R$ 177.96 M |
Share Book Value | R$ 18.16 |
Common Shares | 4,900,000 |
Preferred Shares | 4,900,000 |
Total | 9,800,000 |
Common Shares in Treasury | 11,890 |
Preferred Shares in Treasury | 3,600 |
Total in Treasury | 15,490 |
Common Shares (Except Treasury) | 4,888,110 |
Preferred Shares (Except Treasury) | 4,896,400 |
Total (Except Treasury) | 9,784,510 |
Summary Cash Flow Statement Last 12 Months | |
---|
Operating Cash Flow | R$ 31.28 M |
Cash Flow from Investments | - R$ 2.85 M |
Financing Cash Flow | - R$ 11.06 M |
Increase (Reduction) in Cash and Equivalents | R$ 17.37 M |
Summary Cash Flow Statement Last Quarter | |
---|
Operating Cash Flow | R$ 7.68 M |
Cash Flow from Investments | - R$ 2.13 M |
Financing Cash Flow | R$ 3.54 M |
Increase (Reduction) in Cash and Equivalents | R$ 9.09 M |
Experimental CAPEX and Free Cash Flow Calculation | |
---|
CAPEX 3 months | - R$ 2.24 M |
Free Cash Flow 3 months | R$ 5.44 M |
CAPEX 12 months | - R$ 7.72 M |
Free Cash Flow 12 months | R$ 23.56 M |